Amryt Pharma Holdings Ltd
LSE:AMYT
Amryt Pharma Holdings Ltd
LSE:AMYT
Price:
143 GBX
-11.73%
Updated:
May 7, 2024
Amryt Pharma Holdings Ltd
Cash from Investing Activities
|
Amryt Pharma Holdings Ltd
Cash from Investing Activities Peer Comparison
Comparables:
GSK
AZN
INDV
HIK
DPH
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Amryt Pharma Holdings Ltd
LSE:AMYT
|
Cash from Investing Activities
-$2.4m
|
CAGR 3-Years
-87%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
N/A
|
|
|
GlaxoSmithKline PLC
LSE:GSK
|
Cash from Investing Activities
-£1.3B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
24%
|
CAGR 10-Years
N/A
|
|
|
AstraZeneca PLC
LSE:AZN
|
Cash from Investing Activities
-$5.2B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
2%
|
|
|
Indivior PLC
LSE:INDV
|
Cash from Investing Activities
$54m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Hikma Pharmaceuticals PLC
LSE:HIK
|
Cash from Investing Activities
-$333m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-28%
|
CAGR 10-Years
-11%
|
|
|
Dechra Pharmaceuticals PLC
LSE:DPH
|
Cash from Investing Activities
-£426.2m
|
CAGR 3-Years
-74%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
-36%
|
See Also
What is Amryt Pharma Holdings Ltd's Cash from Investing Activities?
Cash from Investing Activities
-2.4m
USD
-2.4m
USD
Based on the financial report for Dec 31, 2020, Amryt Pharma Holdings Ltd's Cash from Investing Activities amounts to -2.4m USD.
What is Amryt Pharma Holdings Ltd's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 5Y
-17%
-17%
The average annual Cash from Investing Activities growth rates for Amryt Pharma Holdings Ltd have been -87% over the past three years , -17% over the past five years .
You don't have any saved screeners yet
